Rein Therapeutics, Inc. Impairment of Long-Lived Assets to be Disposed of
Rein Therapeutics, Inc. (RNTX) reported Impairment of Long-Lived Assets to be Disposed of of $28.70 million for the 3-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2026-03-26
- Rein Therapeutics, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2025-12-31 was $28.70M, a 77467.57% increase year-over-year.
- Rein Therapeutics, Inc. impairment of long-lived assets to be disposed of for the quarter ending 2024-12-31 was $37.00K.
- Rein Therapeutics, Inc. impairment of long-lived assets to be disposed of for fiscal 2023 was $0.00.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|
| 2025-12-31 | $28.70M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $37.00K 10-K · filed 2025-04-07 | |
| 2023-12-31 | $0.00 10-K · filed 2024-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |